NCT00003257 2013-12-04Gene Therapy in Treating Patients With Recurrent Head and Neck CancerNational Cancer Institute (NCI)Phase 2 Unknown39 enrolled
NCT00041613 2008-04-01Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving MethotrexateIntrogen TherapeuticsPhase 3 Unknown